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osting by EAbstract Background: We report the clinical and histopathological features of discoid lupus ery-
thematosus (DLE) in a group of Saudi patients, and provide a basic framework for a subsequent
larger, prospective study.
Methods: DLE patients seen and diagnosed at the Dermatology Clinic of King Khalid University
Hospital, King Saud University, Riyadh, Saudi Arabia, between January 1998 and December 2010
were retrospectively studied. Data included demographics, duration of the disease, precipitating and
aggravating factors, clinical type, immunological markers and histopathological ﬁndings.
Results: Of the 56 DLE patients, females outnumbered males by 1.5:1. Mean age of onset was
36.5 ± 13.7 years and mean duration of the disease was 18.5 ± 24.6 months. Majority of patients
(91.1%) had atrophic type. The scalp and face were the commonest sites of involvement. Antinu-
clear antibodies (ANA) were positive in nine patients (16.1%). Eight (14.3%) were positive for
DsDNA. Fifty-two (92.9%) showed dermal inﬁltration, 38 (67.9%) with periappendigeal inﬁltrates
and 31 (55.4%) with lichenoid reaction and vacuolar degeneration. Fifty-one patients (91.1%)artment of Dermatology (82),
Saud University, P.O. Box
.: +966 14691459; fax: +966
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10 F.M. Al-Saif et al.received treatment; 31 (60.8%) had improvement of the lesions whereas six patients (11.8%)
progressed to systemic lupus erythematosus (SLE). Progression of the disease was signiﬁcantly
correlated with age of onset (p= 0.044) but not to duration of the disease, gender, immunological
markers, histopathological features or treatment.
Conclusion: The propensity of some patients progressing to systemic lupus should be given atten-
tion through early diagnosis, patient education and appropriate management.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Background
Discoid lupus erythematosus (DLE) is a chronic skin condition
that occurs in the face, ears, and scalp and at times on other
body areas (Bajaj et al., 2010; Khelifa et al., 2007; Patel and
Werth, 2002). Typically, discoid lupus is characterized by ery-
thematous macules, papules, and plaques with telangiectasia,
scaling and follicular plugs, which results in a scarring process
with atrophy and dyspigmentation (Lin et al., 2007). They may
present with mild pruritus or sometimes pain within the
lesions. DLE occurs in genetically predisposed individuals
and tends to run in families, but the exact genetic connection
is unknown. It is thought to be autoimmune with the body’s
immune system incorrectly attacking normal skin (Bajaj
et al., 2010; Khelifa et al., 2007; Patel and Werth, 2002).
Some reports showed the association between discoid lupus
erythematosus and sunlight and cigarette smoking (Miot
et al., 2005).
Studies report an average annual incidence between 2.59
and 48 per 100,000 people (Bajaj et al., 2010; Khelifa et al.,
2007; Deligny et al., 2010). It may occur at any age mostly
at age more than 20 years and uncommon in childhood
(Khelifa et al., 2007; Deligny et al., 2010; Insawang et al.,
2010; Samapaio et al., 2008; Cherif et al., 2003). Females are
more predisposed to DLE than males in a ratio of 3:1 (Bajaj
et al., 2010; Khelifa et al., 2007). Diagnosis of discoid lupus
is generally made based on clinical features. Histology may
be required to conﬁrm the diagnosis; it is that of a lichenoid
tissue reaction with changes at the dermo-epidermal junction
that include thickening of the basement membrane and vacuo-
lar degeneration of the basal cells along with perivascular and
periappendigeal inﬂammatory cell inﬁltration of variable
degrees in the reticular dermis (Panjwani, 2009). Direct immu-
noﬂuorescence (DIF) in lesional skin is not speciﬁc and its
absence does not eliminate the diagnosis of DLE. DIF can
be helpful in establishing the diagnosis of DLE, in 80% of
cases granular deposits of immunoglobulins G and M (IgG
and IgM), and C3 are present along the basement membrane
zone (Kontos et al., 2005). Patients with DLE rarely have
clinically signiﬁcant systemic disease however, the condition
can go widespread and between 20% and 50% of patients
progress to systemic lupus erythematosus (SLE) (Ng et al.,
2000; Al-Hattab and Al-Waiz, 2004).
To date, information on DLE affecting Saudi nationals has
been scanty and none has been published so far. To our
knowledge, this article is the ﬁrst study of this kind to examine
this group of patients, and provide a basic framework for a
subsequent larger, prospective study.2. Methods
We studied 56 patients with DLE who were seen and diag-
nosed at the Dermatology Clinic of King Khalid University
Hospital, King Saud University, Riyadh, Saudi Arabia,
between January 1998 and December 2010. Demographic
characteristics of these patients were recorded including age,
sex, age at onset and duration of the disease, precipitating
and aggravating factors, and clinical type. A thorough physical
examination was conducted to record the site of the lesion, the
symmetry and distribution of the lesion and other cutaneous
and systemic abnormalities. Laboratory investigations includ-
ing antinuclear antibodies (ANA) and other immunological
markers were noted. Double-stranded deoxyribonucleic acid
(DsDNA) was analyzed by enzyme-linked immunosorbent
assay (ELISA) using Quanta-Lite dsDNA ELISA diagnostic
kit (Inova Diagnostics, Inc., San Diego, CA, USA). ANA
was analyzed using ANA/HEp-2 cell culture immunoﬂuores-
cent assay test system kit (Zeus Scientiﬁc, Inc., New Jersey,
USA). Biopsies were taken from all patients for histopatholo-
gical examination by hematoxylin and eosin staining.
Data obtained were encoded in Microsoft Excel 2007 and
exported to Predictive Analysis Software (PASW) version
18.0 (IBM, Chicago, IL, USA) for analysis. Results were ex-
pressed as mean, standard deviation and in percentage fre-
quencies. Correlations were done using Pearson’s correlation
coefﬁcient and independent t-test where appropriate. p values
<0.05 were considered statistically signiﬁcant.3. Results
Of these 56 patients, 33 (58.9%) were females and 23 (41.1%)
were males. Female to male distribution was 1.5:1 with female
preponderance. Mean age of onset was 36.5 ± 13.7 years
(range: 10–68 years). Mean duration of the disease was
18.5 ± 24.6 months (range: 1–120 months). Fifty-one (91.1%)
patients had atrophic type, three (5.4%) had annular and two
(3.6%) had the psoriasiform type of DLE. Family history of
DLE was noted in one patient (1.8%).
Table 1 shows the sites of involvement. The scalp and face
were the commonest sites of involvement (42.9% and 32.1%,
respectively). Eighteen of these patients (32.1%) reported
exacerbation of the lesions by sunlight.
Antinuclear antibodies (ANA) were positive in nine pa-
tients (16.1%) with a titer ranging between 1:160 and 1:5120.
Eight patients (14.3%) were positive for DsDNA, one patient
(1.8%) had low C4 and one patient (1.8%) was positive for
Table 1 Sites of lesions in 56 patients with DLE.
Site No. of cases %
Scalp 24 42.9
Face 18 32.1
Nose 4 7.1
Back 3 5.4
Cheeks 3 5.4
Forehead 3 5.4
Upper extremities 3 5.4
Lower extremities 2 3.6
Chest 2 3.6
Ears 2 3.6
Palms 1 1.8
Trunk 1 1.8
Neck 1 1.8
Table 2 Histopathological ﬁndings in 56 patients with DLE
lesions.
Feature No. of cases %
Superﬁcial/deep dermal inﬁltrates 52 92.9
Periappendigeal inﬁltrates 38 67.9
Lichenoid reaction/vacuolar degeneration 31 55.4
Atrophy of epidermis 25 44.6
Thickening of basement membrane 24 42.9
Hyperkeratosis 15 26.8
Keratolic plugs 15 26.8
Civatte bodies 10 17.9
Figure 1 Lupus over the nasal bridge in a 25-year-old male
patient.
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for mucin.
Table 2 shows the histopathological ﬁndings. There were 52
patients (92.9%) with superﬁcial deep dermal inﬁltration, 38
(67.9%) with periappendigeal inﬁltrates, 31 (55.4%) with
lichenoid reaction and vacuolar degeneration, 25 (44.6%) with
epidermal atrophy, 24 (42.9%) patients showed thickening of
the basement membrane, 15 patients (26.8%) had hyperkera-
tosis and keratolic plugs and 10 (17.9%) had civatte bodies
on histopathology.
Fifty-one patients (91.1%) received treatment; 29 (56.9%)
with topical corticosteroids, 27 (52.9%) with sunblock, 21
(41.2%) with hydroquinone, and a few patients with azathio-
prine, combination of hydroquinone + retinoic acid + hyr-
drocortisone, intra-lesional corticosteroid and Methotrexate.
Of these 51 patients who received treatment, 31 (60.8%) had
either clearing or improvement of the lesions, 1 (1.9%) showed
no improvement, one (1.9%) had post-inﬂammatory hyperpig-
mentation, two (3.9%) had scarring alopecia, one (1.9%) still
under treatment and six (11.8%) progressed to systemic lupus
erythematosus (SLE). Ten patients (19.6%) were lost to fol-
low-up.
Comparative analyses of all variables between patients,
who improved, became stable or had the disease resolved ver-
sus patients who progressed to SLE revealed no signiﬁcant
ﬁndings. Patients who improved were older and had a shorter
duration of the disease compared to those who progressed
(age: 37.61 ± 12.7 versus 28.0 ± 16.3 years, p= 0.1135,
95% CI 2.4091 to 21.6291) and (duration: 19.5 ± 26.5 versus10.5 ± 9.5 months, p= 0.4213, 95% CI 13.45 to 31.45).
Those who progressed to SLE had more sunlight exposure
(50% versus 32.3%, p= 0.7144), more positivity with ANA
(50% versus 19.3%, p= 0.5673) and more positivity to
DsDNA (66.7% versus 12.9%, p= 0.8313).
Furthermore, the histopathological features of those who
had disease progression showed more features of lichenoid
reaction, vacuolar degeneration, deep dermal inﬁltration and
periappendigeal appendages than those who improved or were
stable (p> 0.05). Progression of the disease was signiﬁcantly
correlated with age of onset (r= 0.317, p= 0.044) and not
signiﬁcantly correlated to duration of the disease, gender,
histopathological features or treatment.
4. Discussion
Our study showed results comparable to those reported in the
literature, with mean age of onset of 36.5 years and female to
male ratio of 1.5:1 (Bajaj et al., 2010; Khelifa et al., 2007;
Deligny et al., 2010; Insawang et al., 2010; Samapaio et al.,
2008; Cherif et al., 2003). The exact pathological characteristic
pattern and cause of DLE development is still to be reported;
however, a complex interplay of genetics, environmental
factors, and other factors may lead to the development of
the disease. Considering that our study population is homoge-
nous, i.e. of Arab descent, our ﬁndings correspond to those
reported in the literature. This suggests that ethnicity may
not have to do with the pathogenesis and development of
DLE. We found that the scalp and face were involved in
42.9% and 32.1% of patients respectively, similar to those
reported in the literature (Bajaj et al., 2010; Khelifa et al.,
2007; Patel and Werth, 2002). This holds through that DLE
lesions in the face associated with scarring alopecia of the scalp
signify initial lesions in the scalp in the very early stages of the
disease (Al-Hattab and Al-Waiz, 2004). We incorporated two
pictures to show some lesions of our patients. Fig. 1 shows a
lupus over the nasal bridge in a 25-year-old male patient.
Fig. 2 shows an atrophic DLE in front of left ear in a
14-year-old male patient.
In contrast to the ﬁndings among Iraqis, only 16.1% of our
patients showed positivity to ANA (Al-Hattab and Al-Waiz,
2004). We found that the percentage of patients progressing
to SLE was 11.8%, which is lower than the reported percent-
ages of 20–50% (9–10) in the literature but is slightly higher
than that reported from Iraqi patients (Al-Hattab and
Al-Waiz, 2004). Histopathological features were also similar
Figure 2 An atrophic DLE in front of left ear in a 14-year-old
male patient.
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et al., 2007; Patel and Werth, 2002).
One signiﬁcant ﬁnding that we discovered is that patients
who improved were older and had a shorter duration of the
disease compared to those who progressed. Regression analy-
sis on factors correlated with progression of the disease re-
vealed signiﬁcant correlation with age of onset of the disease.
This suggests that development of DLE at a younger age
(younger than 30 years old) have a greater likelihood that
the disease may progress to SLE. This idea of age of onset
to progression of the disease correlation has not been reported
in the literature. Although, several studies have implied that
DLE when appearing in childhood can have greater propensity
towards transition to a systemic one (Panjwani, 2009; Van
Gysel et al., 2002). This study has evaluated the disease
particularly among Saudis, thus we hope that through our
evaluation of DLE, more studies will shed light on the rela-
tionship of childhood-onset or early onset of the disease and
progression to a systemic disease. This then calls for an early
diagnosis, prompt intervention and appropriate management
of the disease.References
Al-Hattab, M.K., Al-Waiz, M., 2004. Discoid lupus erythematosus in
Iraqi patients: a clinical and histopathological study. Ann. Saudi
Med. 24, 289–292.
Bajaj, D.R., Devrajani, B.R., Matlani, B.L., 2010. Discoid lupus
erythematosus: a proﬁle. J. Coll. Physicians Pak. 20, 361–364.
Cherif, F., Mebazza, A., Mokni, M., El Euch, D., Azaiz, M.I.,
Dhahri, A.B., 2003. Childhood discoid lupus erythematosus: a
Tunisian retrospective study of 16 cases. Pediatr. Dermatol. 20,
295–298.
Deligny, C., Clyti, E., Sainte-Marie, D., Couppie, P., Huong du, L.T.,
Piette, J.C., Arﬁ, S., Pradinaud, R., 2010. Incidence of chronic
cutaneous lupus erythematosus in French Guiana: a retrospective
population-based study. Arthritis Care Res. 62, 279–282.
Insawang, M., Kulthanan, K., Chularojanamontri, L., Tuchinda, P.,
Pinkaew, S., 2010. Discoid lupus erythematosus: description of 130
cases and review of their natural history and clinical course. J. Clin.
Immunol. Immunopathol. Res. 2, 1–8.
Khelifa, E., Benmously, R., Fenniche, S., Marrak, H., Zghal, M.,
Mokhtar, I., 2007. Adult discoid lupus erythematosus. Tunis. Med.
85, 205–208.
Kontos, A.P., Jirsari, M., Jacobsen, G., Fivenson, D.P., 2005.
Immunoglobulin M predominance in cutaneous lupus erythema-
tosus. J. Cutan. Pathol. 32, 352–358.
Lin, J.H., Dutz, J.P., Sontheimer, R.D., Werth, V.P., 2007. Patho-
physiology of cutaneous lupus erythematosus. Clin. Rev. Allergy
Immunol. 33, 85–106.
Miot, H.A., Bartoli Miot, L.D., Haddad, G.R., 2005. Association
between discoid lupus erythematosus and cigarette smoking.
Dermatology 211, 118–122.
Ng, P.P., Tan, S.H., Koh, E.T., Tan, T., 2000. Epidemiology of
cutaneous lupus erythematosus in a tertiary referral center in
Singapore. Australas. J. Dermatol. 41, 229–233.
Panjwani, S., 2009. Early diagnosis and treatment of discoid lupus
erythematosus. J. Am. Board Fam. Med. 22, 206–213.
Patel, P., Werth, V., 2002. Cutaneous lupus erythematosus: a review.
Dematol. Clin. 20, 373–385.
Samapaio, M.C., de Oliveira, Z.N., Machado, M.C., dos Reis,
V.M., Vilela, M.A., 2008. Discoid lupus erythematosus in
children – a retrospective study of 34 patients. Pediatr. Derma-
tol. 25, 163–167.
Van Gysel, D., de Waard-van der Spek, F.B., Oranje, A.P., 2002.
Childhood discoid lupus erythematosus: report of ﬁve new cases
and review of the literature. J. Eur. Acad. Dermatol. Venereol. 16,
143–147.
